Skip to content

Randomized controlled trial of acupuncture combined with conventional medical therapy for postherpetic neuralgia.

Randomized controlled trial of acupuncture combined with conventional medical therapy for postherpetic neuralgia.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001654
Enrollment
Unknown
Registered
2026-07-06
Start date
2026-08-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Herpes Zoster Neuralgia

Interventions

Acupuncture + Western Medicine Treatment Group:Real Acupuncture + Western Medical Treatment
Sham acupuncture + Western Medicine Treatment Group:Sham acupuncture + Western Medical Treatment

Sponsors

Chengdu Pidu District Traditional Chinese Medicine Hospital / Chengdu University of Traditional Chinese Medicine Affiliated Third Hospital (West District)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Meets Herpes Zoster Neuralgia diagnostic criteria; (2) Participants aged 18 to 70 years, regardless of gender; (3) 3 points = Visual Analog Scale (VAS) of pain = 7 points; (4) Voluntarily signs the informed consent form and is willing to actively cooperate with the treatment.

Exclusion criteria

Exclusion criteria: (1) Suffering from special types of herpes zoster or herpes zoster on the head, face, perineum; (2) Having a primary disease that threatens life and is related to the heart, brain, liver, lungs, kidneys, hematopoietic system, etc.(2) Having a primary disease that endangers life and is associated with the herpes zoster (such as acute myocardial infarction, severe sequelae of cerebral stroke, malignant arrhythmia, hypertensive crisis, primary cardiomyopathy, acute exacerbation of chronic obstructive pulmonary disease, renal failure, liver failure, leukemia, etc.); other endocrine system diseases presenting as neuralgia; malignant tumors, etc.; (such as acute myocardial infarction, severe sequelae of cerebral stroke, malignant arrhythmia, hypertensive crisis, primary cardiomyopathy, acute exacerbation of chronic obstructive pulmonary disease, renal failure, liver failure, leukemia, etc.); other endocrine system diseases presenting as neuralgia; malignant tumors, etc.; (3) Having hypertension or diabetes, and whose blood pressure and blood sugar are not well controlled (such as those whose systolic blood pressure is =140 mmHg and/or diastolic blood pressure is =90 mmHg after taking medication, fasting blood glucose is =7.(3) Having hypertension or diabetes, and whose blood pressure and blood sugar are not well controlled (such as those whose systolic blood pressure is =140 mmHg and/or diastolic blood pressure is =90 mmHg after taking medication, fa0 mmol/L, or those who do not take medication as prescribed); sting blood glucose is =7.0 mmol/L, or those who do not take medication as prescribed); (4) Having other chronic pain diseases and being in the period of pain attack; (5) Being pregnant or breastfeeding; (4) Having other chronic pain diseases and being in the period of pain attack; (5) Being pregnant or breastfeeding; (6) Allergic to metals or physically weak and unable to tolerate acupuncture; (6) Allergic to metals or physically weak and unable to tolerate acupuncture; (7) Having bleeding disorders, bleeding tendencies, coagulation dysfunction or severe skin infections; (8) Severe drug dependence, drug abuse and alcoholism; (7) Having bleeding disorders, bleeding tendencies, coagulation dysfunction or severe skin infections; (8) Severe drug dependence, drug abuse and alcoholism; (9) Having received acupuncture treatment for pain-related diseases within the past six months or participating in other drug clinical research.(9) Having received acupuncture treatment for pain-related diseases within the past six months or participating in other drug clinical research.

Design outcomes

Primary

MeasureTime frame
Response Rate;

Secondary

MeasureTime frame
Visual Analog Scale;Short Form of McGill Pain Questionnaire;Pain-DETECT questionnaire ;douleur neuropathique 4 questionsnaire;Dermatology Life Quality Index;Zung Self-Rating Anxiety Scale;Zung Self-Rating Depression Scale;Pittsburgh Sleep Quality Index;The incidence rate of Postherpetic Neuralgia;The proportion of people taking painkillers in this group, as well as the dosage of painkillers consumed;

Countries

China

Contacts

Public ContactZhao Ling

Chengdu University of Traditional Chinese Medicine

ling94@163.com13568801429

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Aug 10, 2026